Navigation Links
CuraGen and TopoTarget Announce New Clinical Results With,Belinostat to be Reported at Upcoming Major Medical Meetings

on is a biopharmaceutical company developing diverse approaches, including novel protein, antibody, antibody- drug conjugate and small molecule therapeutics. By leveraging the drug development strengths cultivated over the years, CuraGen expects to make a difference by advancing its promising therapeutics to address the unmet medical needs of patients with cancer and inflammatory diseases. CuraGen is focused on bringing velafermin, belinostat and CR011-vcMMAE through clinical development, and maintains a portfolio of earlier-stage compounds that have the potential to treat cancer and inflammatory diseases. CuraGen Corporation is headquartered in Branford, Connecticut. For additional information please visit http://www.curagen.com.

About TopoTarget

TopoTarget (CSE: TOPO) is a biopharmaceutical company, headquartered in Denmark and with subsidiaries in the UK and Germany, dedicated to finding "Answers for Cancer" and developing improved cancer therapies. TopoTarget is founded and run by clinical cancer specialists and combines years of hands-on clinical experience with in-depth understanding of the molecular mechanisms of cancer. Focus lies on highly predictive cancer models and key cancer enzyme regulators (mainly HDAC, mTOR, and topoisomerase II inhibitors) and a strong development foundation has been built. TopoTarget has a broad portfolio of small molecule preclinical drug candidates and seven drugs are in clinical development, including both novel anti-cancer therapeutics and new cancer indications for existing drugs. Savene(TM) is TopoTarget's first product on the market. In addition to organic growth, TopoTarget consistently looks for opportunities to strengthen and expand its activities through acquisitions and in-licensing. For more information, please refer to http://www.topotarget.com.

Safe Harbor

Statements in this pr
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. CuraGen Presents Update on Clinical Development Program for Belinostat
2. CuraGen Announces New Preclinical Results with Belinostat and Velafermin to be Presented at AACR Annual Meeting
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:12/15/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that an overall survival benefit would ... surveyed European oncologists in their decision to prescribe ... treatment of breast cancer. ,, The new Special ... European Trends in Targeted Therapies in Breast Cancer: ...
(Date:12/15/2009)... Accumetrics, Inc., developer and marketer of the VerifyNow® ... for measuring an individual,s response to multiple antiplatelet ... the number of international and U.S. distribution agreements, ... significant capital financing that will take the company ... continued its commitment to creating a powerful, worldwide ...
(Date:12/14/2009)... LONDON, Dec. 14 The 2009 Frost ... the Ultrasound Market is conferred on SonoScape. The ... - the need for special features, pricing, and ... (HCU). The performance of this high-end colour ... high-end, cart-based echo ultrasound system. ,, ...
Breaking Medicine Technology:For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3Accumetrics Closes 2009 with Positive Outlook 2Accumetrics Closes 2009 with Positive Outlook 3Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 2Frost & Sullivan Product Quality Leadership Award in the European Ultrasound Market Conferred on SonoScape for S8 3MDS Reports Second Quarter 2009 Financial Results 48568 1MDS Reports Second Quarter 2009 Financial Results 48568 2MDS Reports Second Quarter 2009 Financial Results 48568 3MDS Reports Second Quarter 2009 Financial Results 48568 4MDS Reports Second Quarter 2009 Financial Results 48568 5MDS Reports Second Quarter 2009 Financial Results 48568 6MDS Reports Second Quarter 2009 Financial Results 48568 7MDS Reports Second Quarter 2009 Financial Results 48568 8MDS Reports Second Quarter 2009 Financial Results 48568 9MDS Reports Second Quarter 2009 Financial Results 48568 10MDS Reports Second Quarter 2009 Financial Results 48568 11MDS Reports Second Quarter 2009 Financial Results 48568 12MDS Reports Second Quarter 2009 Financial Results 48568 13MDS Reports Second Quarter 2009 Financial Results 48568 14MDS Reports Second Quarter 2009 Financial Results 48568 15MDS Reports Second Quarter 2009 Financial Results 48568 16MDS Reports Second Quarter 2009 Financial Results 48568 17MDS Reports Second Quarter 2009 Financial Results 48568 18MDS Reports Second Quarter 2009 Financial Results 48568 19Isis Pharmaceuticals to Present at Jefferies 3rd Annual Healthcare Conference 48563 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 1Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 2Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 3Australia 3A Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight 12575 4
... Cell Therapeutics, Inc. (CTI),(Nasdaq and MTA: ... for the,Zevalin(R) ([90Y]-ibritumomab tiuxetan) First-line Indolent (FIT) ... (ASH) 50th Annual Meeting by,Morschhauser, et al ... following Zevalin consolidation therapy for patients with,follicular ...
... SAN FRANCISCO, Dec. 7 The largest study ever ... help prevent deadly blood clots in patients with cancer ... on Sunday, December 7, at 9:30 a.m., during the ... in San Francisco, CA. Additional research being featured at ...
Other Medicine Technology:Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 2Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 3Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 4Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 2Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 3Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 4Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 5Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 6Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 7Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 8Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer 9
(Date:12/15/2009)... Seattle’s premier organic meal delivery service ( www.delicious-planet.com ) is ... Detox Program, Randi Carter, company founder and CEO reported today. ... ... – Seattle, WA) – Delicious Planet, Seattle’s premier organic meal ... the launch of its Delicious Planet Detox Program, Randi Carter, ...
(Date:12/15/2009)... Dec. 15 Comcast Corporation and Stand Up ... first-ever video-on-demand (VOD) initiative Stand Up 2 Cancer ... funds for innovative cancer research. Debuting exclusively on ... On Demand will feature an extraordinary library of ... of the world,s biggest stars and groups. ...
(Date:12/15/2009)... At a time when Americans spend over $50 billion ... Raymond Hall is theorizing a painful connection between conventional ... called Pillo1 ( www.pillo1.com ) to address the problem. ... John,s Medical Plaza Sleep Disorders Center showed that Pillo1 ... position and promotes increased time spent in REM (rapid ...
(Date:12/15/2009)... enable clean transition to new coding system. , ... ... 2009 -- The American Academy of Professional Coders ( AAPC ... training for health plans across the country beginning January. Developed ... coding and reimbursement experts, the on-site trainings are designed to ...
(Date:12/15/2009)... for consultations how will they get paid for patient care? ... terms. , ... Washington, DC (Vocus) ... eliminate consultation codes. These codes are what healthcare providers ... for a medical consultation, whether in a provider’s office or ...
Breaking Medicine News(10 mins):Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 2Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 3Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 5Health News:Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3% 2Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 2Health News:AAPC Now Offers On-site ICD-10 Training for Health Plans Nationwide 3Health News:Medicare Eliminates Consultation Codes for Doctors 2
... study conducted by David Flora, PhD of the University of ... Chassin, PhD of Arizona State University//, says that parental alcoholism ... is generally known that children of alcoholics (COA's) suffer because ... time that a correlation has been established between alcohol abuse ...
... Palmer and his team from Southampton General Hospital, studied ... The research work is aimed at studying the environmental ... exposure to metal fume. ,Researchers found that ... low compared to the normal persons and an absence ...
... in serious trouble with regard to a trip made to ... halt, an eight-year-old health program for meant for the country’s ... Vision that operates the Nayab Health Services project for masseurs ... ,Helped by Britain's Naz Foundation International, Vision began a drop-in ...
... self-esteem and health of people, according to Penn State researchers. ... when compared to those who are happily married. Over a ... unhappy // marriages were interviewed. , ... studies, and demography said that dissolving a unhappy marriage would ...
... earlier research which said that fish was capable of scaling ... are present in fish do not serve to reduce cancer ... has however been // witnessed in the case of people ... ,Several trials have attempted to assess the effects of ...
... have proposed the administration of flu vaccine to all children ... to prevent the incidence of seasonal flu. The dreadful condition, ... winter, had claimed the valuable lives of over 1000 UK ... and Immunisation that addresses important medical issues and provides related ...
Other Medicine News:Health News:Pakistani Gays Land Themselves In Trouble 2
... OcularProtect is a scientifically ... support for visual and full ... 40 key nutrients, including a ... as FloraGLO lutein, lycopene and ...
... Most people take their eyes ... your body, your eyes need proper ... eye health and vision as you ... nutrition is critical to maintaining and ...
Easy-to-use desktop QC data management solution...
Non-Temperature Ablation Catheters...
Medicine Products: